“…Additionally, picroside II attenuated cerebral I/R injury by inhibiting EndoG release from the mitochondria into the cytoplasm ( Li et al, 2018 ) Similarly, baicalein treatment decreased cerebral I/R injury by inhibiting nuclear translocation of AIF in cerebral I/R rats ( Li et al, 2020 ). Many in vivo ( Zhang et al, 2017 ; Zhao et al, 2018b ; Cheng et al, 2019 ; Yin et al, 2020 ; Li et al, 2021 ; Zhang et al, 2021 ; Li et al, 2022b ; Peng et al, 2022 ) and in vitro ( Zhao et al, 2018a ; Feng et al, 2018 ; Liu et al, 2018 ) studies have shown that TCM compounds (e.g., curcumin, artemether, ferulic acid, artemisinin, rhein, astragaloside IV, l-borneol, calenduloside E, ginkgolide K, dehydrocostus lactone, and icariside II) exert protective effects in MCAO animal models or OGD/R cell models by inhibiting BAX/BCL2, caspase-9, caspase-3, cleaved caspase-3, caspase-8, Cyt-c, Bid, Apaf-1, Bad, and p53 ( Figure 4 ).…”